Induction Healthcare Group PLC (LON:INDC), a leading healthcare technology company that helps digitally transform hospitals, has announced a contract with the Royal Free London NHS Foundation Trust (RFL).
The group’s Induction Zesty unit, a leading provider of patient portals to NHS Hospitals, has delivered the My RFL Care patient portal as the first phase of an ambitious roadmap for RFL’s digital patient services in the next two years.
The My RFL Care portal launched in August 2020 and has had significant traction with over 50,000 patients registering and using the service in the first few months. 250,000 patients are expected to adopt the service in the first year.
The RFL combines globally recognised clinical expertise with local and friendly hospital care to represent the best of the NHS. The trust is a world-leader in a range of specialist services, including infectious diseases, immunology, kidney and liver transplantation, cancer care, plastic surgery and vascular surgery. The trust also runs internationally recognised clinical research programmes and is a leading teaching hospital.
Induction Zesty are committed to transforming clinical pathways in acute hospitals by putting the right technology in the hands of the patient. This patient-centric, technology-driven vision delivers superior patient outcomes while reducing whole-system costs for hospitals. It alleviates the strain on hospital resources and embeds a long-term foundation for future improvements.
In a statement, Induction Healthcare joint CEO and Zesty founder, James Balmain, said: “Partnering with Royal Free London, one of the largest and most respected hospitals in the UK, is an important milestone for Induction Zesty. In just a few months, tens of thousands of patients have successfully registered and used the platform. We look forward to supporting the Royal Free London in delivering further enhanced functionality for their patient portal over the coming months.”
RFL group chief digital officer, Glenn Winteringham, added: “The Induction Zesty team have done an outstanding job of delivering the first phase of our digital programme in just eight weeks which gives me a lot of confidence I have the right digital partner to deliver our ambitious roadmap in the future. The early results are very impressive with a high adoption rate among our patients. I am excited by the potential this innovation has to make a real difference to our patients as we address the overhang from the COVID-19 pandemic.”